Skip to content

Clinical trials

Completed Schizophrenia trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Romania Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20044
20051
20062
20078
20087
20094
20105
201111
20124
20136
20142
20151
20163
20172
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.12
Sumitomo Pharma America, Inc.7
AstraZeneca5
Janssen Research & Development, LLC5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.5
Janssen-Cilag International NV4
Alkermes, Inc.3
Eli Lilly and Company3
Forest Laboratories3
H. Lundbeck A/S3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia67
Psychotic Disorders7
Mental Disorders3
Bipolar Disorder2
Cognition Disorders2
Recurrence2
Autistic Disorder1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.